Who owns United Therapeutics Corporation?

Key details on United Therapeutics Corporation (Ticker: UTHR)

Who owns United Therapeutics Corporation?

Is UTHR a good stock to own? Find out who bought United Therapeutics Corporation, who sold United Therapeutics Corporation (UTHR) stock, and who holds a large position in United Therapeutics Corporation.

Fund Name Number of Shares Share Valuation As Of
Schroder Investment Management 64.75M $5.11B Sept. 30, 2013
BNP PARIBAS ARBITRAGE, SNC 12.58M $2.66B March 31, 2014
FMR 3.64M $633.41M June 30, 2015
Vanguard 3.18M $552.59M June 30, 2015
Scopia Management 2.79M $155.88M Sept. 30, 2012
BlackRock Fund Advisors 2.12M $369.32M June 30, 2015
Inves 2.00M $94.60M Dec. 31, 2011
Damian Sousa 1.99M $225.25M Dec. 31, 2013
LSV Asset Management 1.97M $339.12M March 31, 2015
Herndon Capital Management 1.89M $213.75M Dec. 31, 2013
Deutsche Bank Aktiengesellschaft 1.85M $314.63M June 30, 2015
STATE STREET CORPORATION 1.58M $274.04M June 30, 2015
Acadian Asset Management 1.56M $269.70M March 31, 2015
ARONSON JOHNSON ORTIZ 1.56M $201.57M Dec. 31, 2014
Iridian Asset Management 1.55M $270.10M June 30, 2015
Westfield Capital Management Company 1.55M $72.86M March 31, 2012
BANK OF MONTREAL /CAN/ 1.54M $173.59M Dec. 31, 2013
BlackRock Institutional Trust Company, N.A. 1.51M $262.50M June 30, 2015
Jennison Associates 1.50M $70.67M Dec. 31, 2011
Sectoral Asset Management 1.47M $78.76M Dec. 31, 2012
Palo Alto Investors 1.44M $250.48M June 30, 2015
BlackRock Advisors 1.43M $248.66M June 30, 2015
Bank of America Corporation 1.40M $65.92M Dec. 31, 2011
Wellington Management Company 1.39M $84.72M March 31, 2013

Who sold United Therapeutics Corporation?

Fund Name Date Sold Number of Shares Sold Share Valuation
S.A.C. Capital Advisors June 30, 2011 2.18M $120.35M
Barclays June 30, 2011 2.12M $119.99M
Frontier Capital Management March 31, 2011 2.04M $136.82M
Columbia Wanger Asset Management Dec. 31, 2010 1.48M $93.59M